Back to Market Feed

Product Information

COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.7596 per EA under NDC 67877052330. Its NADAC has been published 355 times since Nov 6, 2019.

FDA first approved this application on May 6, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

COLESEVELAM HCL 3.75 G PACKET

Colesevelam hydrochloride
$2.7596per EA

Strength

3.75 g/1

NDC

67877052330

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

COLESEVELAM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210316

FDA Approved

5/6/2019

TE Code

AB

On Market Since

5/9/2019

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 355 times since Nov 6, 2019, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7596 per EA
All-time high$13.4431 (Jan 15, 2020)
All-time low$2.4176 (May 20, 2026)
52-week high$2.7662
52-week low$2.4176
Median price$3.9398
Average price$5.6505
Largest weekly change+44.2% (Feb 23, 2022)
Weeks tracked355
Tracking sinceNov 6, 2019

Price History

1W

+2.0%

1M

+2.0%

3M

+14.1%

6M

-0.2%

1Y

+0.5%

3Y

-26.4%

5Y

-62.3%

All

-79.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

CHOLESTYRAMINE POWDER
Generic
67877029837•Ascend Laboratories, LLC
$0.0880
per GM
CHOLESTYRAMINE POWDER
Generic
24658026693•PuraCap Laboratories LLC
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
24658026697•PuraCap Laboratories LLC
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
27241013451•Ajanta Pharma USA Inc.
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
42806026793•Epic Pharma LLC
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
42806026797•Epic Pharma LLC
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
49884046566•Endo USA Inc.
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
62135000856•Chartwell RX LLC
$0.0946
per GM
CHOLESTYRAMINE POWDER
Generic
68382052842•Zydus Pharmaceuticals (USA) Inc.
$0.0946
per GM
CHOLESTYRAMINE LIGHT POWDER
Generic
24658027197•PuraCap Laboratories LLC
$0.1140
per GM

Frequently asked questions

What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?

The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Ascend Laboratories, LLC, is $2.7596 per EA (NDC 67877052330), effective Aug 19, 2026.

How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?

Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 79.2%. It has been tracked across 355 weekly CMS publications since Nov 6, 2019.

What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?

Since Nov 6, 2019, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.4176 (May 20, 2026) to a high of $13.4431 (Jan 15, 2020), with a median of $3.9398 per EA.

Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?

No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures COLESEVELAM HCL 3.75 G PACKET?

COLESEVELAM HCL 3.75 G PACKET (NDC 67877052330) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.